atenolol has been researched along with Myocardial Ischemia in 65 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 9.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "The aim of this study was to compare the effects on left ventricular function and exercise tolerance of a selective beta-antagonist (atenolol) with those of another selective beta 1-antagonist with vasodilator properties (nebivolol) in patients with ischemic left ventricular dysfunction but no overt congestive heart failure." | 9.08 | Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. ( Chapelle, F; Hager, D; Pouleur, H; Rousseau, MF; Stoleru, L; Van Eyll, C; Van Nueten, L, 1996) |
| "During the postoperative period, the incidence of myocardial ischemia was significantly reduced in the atenolol group: days 0-2 (atenolol 17 of 99 patients; placebo, 34 of 101 patients; P = 0." | 9.08 | Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. ( Browner, W; Hollenberg, M; Layug, B; Li, J; Mangano, DT; Miller, D; Tateo, I; Wallace, A, 1998) |
| "We sought to determine the effect of nifedipine gastrointestinal therapeutic system (GITS) or atenolol on ischemic left ventricular dysfunction induced by mental stress." | 9.08 | Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. ( Andrews, TC; Carlson, W; Cummings, N; Friedman, R; Jacobs, S; MacCallum, G; Mannting, F; Muller, JE; Parker, JD; Stone, PH; Tofler, GH, 1998) |
| "Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 5.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
| "Acute myocardial ischemia was induced by occlusion of the obtuse marginal coronary artery." | 5.31 | Effect of beta-blocker atenolol on spatial dispersion of ventricular repolarization of sheep following acute myocardial ischemia. ( Wang, LX, 2002) |
| "To determine whether, at trough levels, ranolazine improves the total exercise time of patients who have symptoms of chronic angina and who experience angina and ischemia at low workloads despite taking standard doses of atenolol, amlodipine, or diltiazem and to determine times to angina onset and to electrocardiographic evidence of myocardial ischemia, effect on angina attacks and nitroglycerin use, and effect on long-term survival in an open-label observational study extension." | 5.11 | Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. ( Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA, 2004) |
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 5.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "The Circadian Anti-ischemia Program in Europe (CAPE II) compared the efficacy of amlodipine and diltiazem (Adizem XL) and the combination of amlodipine/atenolol and diltiazem (Adizem XL)/isosorbide 5-mononitrate on exercise and ambulatory myocardial ischemia during regular therapy and after omission of medication." | 5.10 | Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. ( Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST, 2002) |
| " To evaluate the effect of antihypertensive treatment on cardiac arrhythmias (CA) and transient episodes of myocardial ischemia (TEMI), we studied 46 hypertensive patients with LVH, divided into four groups randomly treated with enalapril, hydrochlorothiazide (HCTZ), atenolol, or verapamil (SR-V) for 6 months." | 5.09 | Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH. ( Abrignani, MG; Barbagallo, M; Dominguez, LJ; Nardi, E; Novo, G; Novo, S; Strano, A, 2001) |
| "This study was conducted to determine whether rebound ischemia occurs during nitrate-free periods with intermittent cutaneous nitroglycerin therapy in patients with angina pectoris who are receiving background antianginal therapy." | 5.08 | Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. ( Daxini, BV; Freedman, SB; Kelly, DT; Noyce, D, 1995) |
| "The aim of this study was to compare the effects on left ventricular function and exercise tolerance of a selective beta-antagonist (atenolol) with those of another selective beta 1-antagonist with vasodilator properties (nebivolol) in patients with ischemic left ventricular dysfunction but no overt congestive heart failure." | 5.08 | Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. ( Chapelle, F; Hager, D; Pouleur, H; Rousseau, MF; Stoleru, L; Van Eyll, C; Van Nueten, L, 1996) |
| "During the postoperative period, the incidence of myocardial ischemia was significantly reduced in the atenolol group: days 0-2 (atenolol 17 of 99 patients; placebo, 34 of 101 patients; P = 0." | 5.08 | Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. ( Browner, W; Hollenberg, M; Layug, B; Li, J; Mangano, DT; Miller, D; Tateo, I; Wallace, A, 1998) |
| "We sought to determine the effect of nifedipine gastrointestinal therapeutic system (GITS) or atenolol on ischemic left ventricular dysfunction induced by mental stress." | 5.08 | Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. ( Andrews, TC; Carlson, W; Cummings, N; Friedman, R; Jacobs, S; MacCallum, G; Mannting, F; Muller, JE; Parker, JD; Stone, PH; Tofler, GH, 1998) |
| " We also now have another bradycardic agent, ivabradine, which may prove very useful in heart failure patients who cannot tolerate a betablocker." | 4.84 | [What are the alternatives to betablockers in 2009?]. ( van de Borne, P, 2008) |
| " During ischemia alone, the incidence of ventricular fibrillation in animals who underwent all phases of the study was 6 of 9; with atenolol (0." | 3.69 | Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar. ( Fusilli, L; Lee, W; Patel, J; Regan, TJ, 1994) |
| " Beta-blocker use at the 2 dosage levels was associated with significant improvement in survival compared with the nonuse of beta blockers (hazard ratios 0." | 2.71 | Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). ( Andrews, M; Brodine, WN; Daubert, JP; Hall, WJ; Hockstad, ES; Lee, JK; McNitt, S; Moss, AJ; Tung, RT; Zareba, W, 2005) |
| "Treatment with diltiazem resulted in a significant lengthening of sinus cycle length (SCL, p < 0." | 2.67 | Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy. ( Biscione, F; Lanza, GA; Manzoli, A; Natale, A; Santarelli, P, 1994) |
| " After a 4 week run-in period on atenolol, patients were randomly allocated to receive either atenolol alone or its combination with nifedipine and then crossed over to the alternative treatment for a further 4 weeks." | 2.67 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. ( Adnams, C; Commerford, P; Meyer, TE, 1993) |
| "Atenolol treatment reduced daily life ischemia and was associated with reduced risk for adverse outcome in asymptomatic and mildly symptomatic patients compared with placebo." | 2.67 | Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) ( Cohn, PF; Deedwania, PC; Gibson, RS; Handberg, E; Hill, JA; Marks, RG; Miller, E; Pepine, CJ; Thadani, U, 1994) |
| "Both atenolol and diltiazem were of similar efficacy in increasing nonischemic exercise duration in patients with variable-threshold angina and acted primarily by slowing the resting heart rate." | 2.67 | Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina. ( Davies, GJ; Nadazdin, A, 1994) |
| "Atenolol treated patients demonstrated more pronounced respiratory disorders." | 1.33 | [What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?]. ( Aĭsanov, ZR; Chuchalin, AG; Kozlova, LI, 2005) |
| "Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 1.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
| "Acute myocardial ischemia was induced by occlusion of the obtuse marginal coronary artery." | 1.31 | Effect of beta-blocker atenolol on spatial dispersion of ventricular repolarization of sheep following acute myocardial ischemia. ( Wang, LX, 2002) |
| " In the remaining 8 swine, atenolol was infused after 10-min ischemia at a dosage [mean 1." | 1.29 | Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. ( Heusch, G; Rose, J; Schulz, R; Skyschally, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 37 (56.92) | 18.2507 |
| 2000's | 23 (35.38) | 29.6817 |
| 2010's | 5 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuichi, Y | 1 |
| Sakamoto, A | 1 |
| van de Borne, P | 1 |
| Rioufol, G | 1 |
| Finet, G | 1 |
| Reyes, E | 1 |
| Stirrup, J | 1 |
| Roughton, M | 1 |
| D'Souza, S | 1 |
| Underwood, SR | 1 |
| Anagnostopoulos, C | 1 |
| He, G | 1 |
| Hu, J | 1 |
| Li, T | 1 |
| Ma, X | 1 |
| Meng, J | 1 |
| Jia, M | 1 |
| Lu, J | 1 |
| Ohtsu, H | 1 |
| Chen, Z | 1 |
| Luo, X | 1 |
| Monami, M | 1 |
| Filippi, L | 1 |
| Ungar, A | 1 |
| Sgrilli, F | 1 |
| Antenore, A | 1 |
| Dicembrini, I | 1 |
| Bagnoli, P | 1 |
| Marchionni, N | 1 |
| Rotella, CM | 1 |
| Mannucci, E | 1 |
| Deanfield, JE | 2 |
| Detry, JM | 1 |
| Sellier, P | 1 |
| Lichtlen, PR | 1 |
| Thaulow, E | 1 |
| Bultas, J | 1 |
| Brennan, C | 1 |
| Young, ST | 1 |
| Beckerman, B | 1 |
| Kaliuzhin, VV | 1 |
| Tepliakov, AT | 1 |
| Solovtsov, MA | 1 |
| Bossi, M | 1 |
| Tiberti, G | 1 |
| Pedretti, RF | 1 |
| Prete, G | 1 |
| Foreman, RD | 1 |
| Adamson, PB | 1 |
| Vanoli, E | 1 |
| Safonova, EV | 1 |
| Zharova, EA | 1 |
| Samoĭlenko, LE | 1 |
| Sergienko, VB | 1 |
| Chaitman, BR | 3 |
| Pepine, CJ | 7 |
| Parker, JO | 1 |
| Skopal, J | 1 |
| Chumakova, G | 1 |
| Kuch, J | 1 |
| Wang, W | 1 |
| Skettino, SL | 1 |
| Wolff, AA | 2 |
| Monnet, X | 1 |
| Colin, P | 1 |
| Ghaleh, B | 1 |
| Hittinger, L | 1 |
| Giudicelli, JF | 1 |
| Berdeaux, A | 1 |
| Rousseau, MF | 2 |
| Pouleur, H | 2 |
| Cocco, G | 1 |
| Kozlova, LI | 1 |
| Aĭsanov, ZR | 1 |
| Chuchalin, AG | 1 |
| Shangina, OA | 1 |
| Kostin, VI | 1 |
| Koturga, LI | 1 |
| Brodine, WN | 1 |
| Tung, RT | 1 |
| Lee, JK | 1 |
| Hockstad, ES | 1 |
| Moss, AJ | 1 |
| Zareba, W | 1 |
| Hall, WJ | 1 |
| Andrews, M | 1 |
| McNitt, S | 1 |
| Daubert, JP | 1 |
| Karpov, IuA | 1 |
| Sen, A | 1 |
| Fairbairn, T | 1 |
| Levy, F | 1 |
| Bhatt, LK | 1 |
| Nandakumar, K | 1 |
| Bodhankar, SL | 1 |
| Bansal, J | 1 |
| Piplani, P | 1 |
| Ablad, B | 1 |
| Bjurö, T | 1 |
| Björkman, JA | 1 |
| Edström, T | 1 |
| González Maqueda, I | 1 |
| Schulz, R | 1 |
| Rose, J | 1 |
| Skyschally, A | 1 |
| Heusch, G | 1 |
| Freedman, SB | 1 |
| Daxini, BV | 1 |
| Noyce, D | 1 |
| Kelly, DT | 1 |
| Santarelli, P | 1 |
| Biscione, F | 1 |
| Natale, A | 1 |
| Manzoli, A | 1 |
| Lanza, GA | 1 |
| Davies, RF | 5 |
| Habibi, H | 2 |
| Klinke, WP | 2 |
| Dessain, P | 2 |
| Nadeau, C | 2 |
| Phaneuf, DC | 2 |
| Lepage, S | 2 |
| Raman, S | 1 |
| Herbert, M | 1 |
| Foris, K | 1 |
| Lambert, CR | 1 |
| Raymenants, E | 1 |
| Patel, J | 1 |
| Lee, W | 1 |
| Fusilli, L | 1 |
| Regan, TJ | 1 |
| Ruf, G | 1 |
| Trenk, D | 1 |
| Jähnchen, E | 1 |
| Roskamm, H | 1 |
| Geller, NL | 3 |
| Knatterud, GL | 4 |
| Bourassa, MG | 2 |
| Day, P | 1 |
| Goldberg, AD | 2 |
| McMahon, RP | 2 |
| Sopko, G | 3 |
| Pratt, C | 2 |
| Stone, PH | 3 |
| Rogers, WJ | 1 |
| Meyer, TE | 1 |
| Adnams, C | 1 |
| Commerford, P | 1 |
| Cohn, PF | 1 |
| Deedwania, PC | 1 |
| Gibson, RS | 1 |
| Handberg, E | 1 |
| Hill, JA | 2 |
| Miller, E | 1 |
| Marks, RG | 1 |
| Thadani, U | 1 |
| Shalev, Y | 1 |
| Ben-Hur, H | 1 |
| Hagay, Z | 1 |
| Blickstein, I | 1 |
| Epstein, M | 1 |
| Ayzenberg, O | 1 |
| Gelven, A | 1 |
| Caspi, A | 1 |
| Nadazdin, A | 1 |
| Davies, GJ | 1 |
| Linden, W | 1 |
| Buttars, JA | 1 |
| Franklin, BA | 1 |
| Gordon, S | 1 |
| Timmis, GC | 1 |
| Pratt, CM | 1 |
| Goldstein, S | 1 |
| Andrews, TC | 2 |
| Dyrda, I | 1 |
| Frishman, WH | 1 |
| Morgan, NA | 1 |
| Conti, CR | 3 |
| Lezaun, R | 1 |
| Maraví, C | 1 |
| Gervás, H | 1 |
| Madariaga, I | 1 |
| Basterra, N | 1 |
| de los Arcos, E | 1 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| van Campen, CM | 1 |
| Visser, FC | 1 |
| Visser, CA | 1 |
| Chapelle, F | 1 |
| Van Eyll, C | 1 |
| Stoleru, L | 1 |
| Hager, D | 1 |
| Van Nueten, L | 1 |
| Schweizer, J | 1 |
| Kaulen, R | 1 |
| Nierade, A | 1 |
| Altmann, E | 1 |
| Killip, T | 1 |
| Forman, S | 1 |
| Geller, N | 1 |
| Deanfield, J | 1 |
| Wallace, A | 2 |
| Mangano, DT | 2 |
| Layug, B | 1 |
| Tateo, I | 1 |
| Li, J | 1 |
| Hollenberg, M | 1 |
| Browner, W | 1 |
| Miller, D | 1 |
| Cohen, AT | 1 |
| Pierdomenico, SD | 1 |
| Bucci, A | 1 |
| Costantini, F | 1 |
| Lapenna, D | 1 |
| Cuccurullo, F | 1 |
| Mezzetti, A | 1 |
| Lustik, SJ | 1 |
| Chhibber, AK | 1 |
| Eichelberger, JP | 1 |
| Leung, JM | 1 |
| Parker, JD | 1 |
| Jacobs, S | 1 |
| Friedman, R | 1 |
| Cummings, N | 1 |
| MacCallum, G | 1 |
| Mannting, F | 1 |
| Tofler, GH | 1 |
| Carlson, W | 1 |
| Muller, JE | 1 |
| Wang, JX | 1 |
| Maruyama, K | 1 |
| Murakami, M | 1 |
| Endo, T | 1 |
| Komatsu, H | 1 |
| Akahane, M | 1 |
| Allibardi, S | 1 |
| Merati, G | 1 |
| Chierchia, S | 1 |
| Samaja, M | 1 |
| Owens, P | 1 |
| O'Brien, E | 1 |
| Glasser, SP | 1 |
| Frishman, W | 1 |
| White, WB | 1 |
| Stone, P | 1 |
| Johnson, MF | 1 |
| Greenfield, JR | 1 |
| Chisholm, DJ | 1 |
| Mitrovic, V | 1 |
| Miskovic, A | 1 |
| Strau, M | 1 |
| Thormann, J | 1 |
| Pitschner, H | 1 |
| Hamm, C | 1 |
| Novo, S | 1 |
| Abrignani, MG | 1 |
| Novo, G | 1 |
| Nardi, E | 1 |
| Dominguez, LJ | 1 |
| Strano, A | 1 |
| Barbagallo, M | 1 |
| Fox, KM | 1 |
| Mulcahy, DA | 1 |
| Patrizi, R | 1 |
| Leonardo, F | 1 |
| Pelliccia, F | 1 |
| Chierchia, SL | 1 |
| Galetta, P | 1 |
| Cerquetani, E | 1 |
| Frascà, F | 1 |
| Fini, M | 1 |
| Rosano, GM | 1 |
| Zaglavara, T | 1 |
| Haaverstad, R | 1 |
| Cumberledge, B | 1 |
| Irvine, T | 1 |
| Karvounis, H | 1 |
| Parharidis, G | 1 |
| Louridas, G | 1 |
| Kenny, A | 1 |
| Wang, LX | 1 |
| Ferraro, S | 1 |
| Maddalena, G | 1 |
| D'Agosto, V | 1 |
| D'Alto, M | 1 |
| Fazio, S | 1 |
| Santomauro, M | 1 |
| Romano, M | 1 |
| Chiariello, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000478] | Phase 3 | 0 participants | Interventional | 1990-11-30 | Completed | ||
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for atenolol and Myocardial Ischemia
| Article | Year |
|---|---|
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvast | 2014 |
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failur | 2008 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabet | 2013 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Best evidence topic report. Beta-Blockers in cocaine induced acute coronary syndrome.
Topics: Adrenergic beta-Antagonists; Atenolol; Cocaine-Related Disorders; Contraindications; Humans; Myocard | 2006 |
[Silent myocardial ischemia. Arguments in favor of treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Calcium Channel Blockers; | 1996 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Blood Pressure; C | 2000 |
Circadian variation of the total ischemic burden and influence by beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Circadian Rhythm; Coronary Disease; Humans; Monitori | 1990 |
32 trials available for atenolol and Myocardial Ischemia
| Article | Year |
|---|---|
Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
Topics: Adenosine; Adrenergic beta-Antagonists; Aged; Atenolol; Blood Pressure; Coronary Angiography; Corona | 2010 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabet | 2013 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel B | 2002 |
[Effect of long-term myocardial unloading with beta1-adrenoblocker atenolol on the state of the left ventricle in patients with moderate ischemic dysfunction of the heart as shown by doppler echocardiography].
Topics: Adrenergic beta-Antagonists; Atenolol; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; | 2002 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Chan | 2004 |
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Ateno | 2005 |
Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Fe | 2005 |
Prevention of ventricular fibrillation requires central beta-adrenoceptor blockade in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Baroreflex; Blood Pressure; Central Nervous System; | 2007 |
Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Cholesterol; | 1994 |
Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel B | 1995 |
Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
Topics: Adult; Aged; Amlodipine; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electroph | 1994 |
Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
Topics: Amlodipine; Atenolol; Cross-Over Studies; Drug Therapy, Combination; Electrocardiography, Ambulatory | 1995 |
Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade.
Topics: Atenolol; Circadian Rhythm; Cross-Over Studies; Diltiazem; Double-Blind Method; Electrocardiography, | 1995 |
Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzopyrans; Blood Pressure; Co | 1994 |
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Topics: Aged; Angina Pectoris; Atenolol; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide Di | 1994 |
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.
Topics: Aged; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide D | 1994 |
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Double-Blin | 1993 |
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
Topics: Activities of Daily Living; Atenolol; Double-Blind Method; Electrocardiography, Ambulatory; Female; | 1994 |
Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
Topics: Aged; Angina Pectoris, Variant; Atenolol; Blood Pressure; Coronary Angiography; Diltiazem; Double-Bl | 1994 |
Relative importance of psychologic traits and severity of ischemia in causing angina during treadmill exercise. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
Topics: Amlodipine; Angina Pectoris; Atenolol; Exercise Test; Exercise Tolerance; Female; Humans; Male; Midd | 1993 |
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
Topics: Angina Pectoris; Atenolol; Case-Control Studies; Delayed-Action Preparations; Diltiazem; Drug Therap | 1996 |
Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Benzopyrans; Double-Blind Method; Ethanolamines; | 1996 |
Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
Topics: Adrenergic beta-Antagonists; Aged; Arterial Occlusive Diseases; Atenolol; Blood Flow Velocity; Celip | 1997 |
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Atenolol; Calcium Channel Blocker | 1997 |
Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Double-Blind Method; Electrocardiography; Female; Hemod | 1998 |
Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian | 1998 |
Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Cross-Over Studies; Diastole; Double-Blind Metho | 1998 |
Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Bridged Bicycl | 2000 |
Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood | 2001 |
Circadian variation of the total ischemic burden and influence by beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Circadian Rhythm; Coronary Disease; Humans; Monitori | 1990 |
Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease | 2001 |
Clinical investigation of asymptomatic cardiac ischemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atenolol; Coronary Artery Bypass; Coronary Disease; | 1991 |
26 other studies available for atenolol and Myocardial Ischemia
| Article | Year |
|---|---|
Non-atherosclerotic mild anterior myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Atenolol; Collateral Circulation; Coronary Angiography; Coronary Circul | 2010 |
Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Famotidine; Heart; Heart Rate; Hist | 2012 |
[Ischemic heart disease in patients with arteriopathies].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Antihypertensive Agents; Arterioscle | 2002 |
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Dru | 2003 |
[Preliminary data on combined assessment of tolerance to exercise, left ventricular contractile function in ischemic heart disease patients taking bradycardic agents].
Topics: Atenolol; Bradycardia; Diltiazem; Electrocardiography; Exercise; Heart Rate; Heart Ventricles; Human | 2003 |
Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Blood Pressure; Const | 2004 |
[What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Male; Middle Aged; Myocardial Ischemia; | 2005 |
[Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Atenolol; Calcium Channel Blockers; Depression; Dise | 2005 |
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Benzylamines; Female; Guinea P | 2007 |
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
Topics: Adenosine Triphosphate; Animals; Atenolol; Benzazepines; Blood Pressure; Bradycardia; Cardiovascular | 1995 |
Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Disease Models, Animal; Dogs; Heart | 1994 |
Successful delivery following myocardial ischemia during the second trimester of pregnancy.
Topics: Acute Disease; Adult; Atenolol; Cardiac Catheterization; Coronary Angiography; Female; Heparin; Huma | 1993 |
Diurnal variation of ischemic response to exercise in patients receiving a once-daily dose of beta-blockers. Implications for exercise testing and prescription of exercise and training heart rates.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Atenolol; Blood Pressure; Circadian Rhy | 1996 |
The QRS score: a promising new exercise score for detecting coronary artery disease based on exercise-induced changes of Q-, R- and S-waves: a relationship with myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Coronary Disease; Electrocardiography; Exercise Test; F | 1996 |
Silent myocardial ischemia: some good news.
Topics: Adrenergic beta-Antagonists; Atenolol; Calcium Channel Blockers; Combined Modality Therapy; Coronary | 1997 |
Use of beta-blockade to prevent death after noncardiac surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Humans; Intraoperative Complications; M | 1997 |
Prevention of perioperative myocardial ischaemia and its complications.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Anesthesia; Atenolol; Humans; Imidazoles; Mo | 1998 |
Effects of atenolol on postoperative myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Myocardial Ischemia; Postoperative Complications | 1998 |
Beta blockade in non-cardiac surgical patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Myocardial Ischemia; Postoperative Complications | 1998 |
Antianginal effects of ranolazine in various experimental models of angina.
Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Anesthesia; Angina Pectoris; Animal | 1999 |
Atenolol depresses post-ischaemic recovery in the isolated rat heart.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adrenergic beta-Antagonists; Analysis of Variance; Anim | 1999 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Amb | 1999 |
Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Diabetes Mell | 2000 |
Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; | 2002 |
Effect of beta-blocker atenolol on spatial dispersion of ventricular repolarization of sheep following acute myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Electrocardiography; Heart V | 2002 |
Influence of atenolol on the relationship between heart rate and QT interval in patients with exercise-induced myocardial ischemia.
Topics: Administration, Oral; Angina Pectoris; Atenolol; Coronary Disease; Electrocardiography; Exercise Tes | 1992 |